Upper-respiratory infections are humanity’s most common illness—and the third-leading killer when inflammation scars delicate lung tissue. SJP-002C shields those tissues first: its pre-emptive PAIR mechanism calms mast-cell cascades while an integrated antiviral keeps viral load in check. Expect shorter illness, milder symptoms, and clinically proven, rapid easing of breathlessness—an endpoint most current therapeutics fail to measure, yet every patient counts with every precious breath.
